Meloxicam Tetrafarma

Meloxicam, the active ingredient in Meloxicam Tetrafarma, is a Nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It is used to relieve pain and inflammation associated with osteoarthritis, rheumatoid arthritis, and acute musculoskeletal conditions in adult patients.

GNH USA supplies Meloxicam Tetrafarma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with EU manufacturing standards and is distributed under strict quality controls.

Meloxicam belongs to the NSAID class and is indicated for inflammatory joint and musculoskeletal disorders.

- Osteoarthritis: reduces joint pain and swelling, improving mobility. - Rheumatoid arthritis: alleviates inflammatory joint symptoms and slows functional decline. - Acute musculoskeletal pain: provides rapid analgesia for injuries or post‑operative discomfort.

Meloxicam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Peripheral edema: swelling of the lower limbs. - Elevated blood pressure. - Skin rash or pruritus.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Cardiovascular events such as myocardial infarction or stroke. - Hepatic enzyme elevation or liver injury. - Severe skin reactions (e.g., Stevens‑Johnson syndrome). - Acute renal impairment or failure. - Anaphylactic or severe hypersensitivity reactions.

Before prescribing Meloxicam, clinicians should evaluate patient‑specific risk factors and monitor for adverse outcomes.

- Renal function: monitor in patients with existing kidney disease. - Cardiovascular risk: use cautiously in patients with hypertension or heart disease. - Gastrointestinal risk: assess history of ulcers or bleeding. - Pregnancy and lactation: avoid unless benefits outweigh risks. - Drug interactions: review concomitant NSAIDs, anticoagulants, and antihypertensives. - Store at ambient temperature: keep in original container, protect from moisture and light.

Meloxicam can interact with several drug classes, requiring careful assessment.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Selective COX‑2 inhibitors: additive toxicity. - Lithium: increased serum lithium levels. - Methotrexate: reduced clearance and potential toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible renal function changes. - Diuretics: heightened risk of renal impairment. - SSRIs or SNRIs: increased bleeding tendency.